157 related articles for article (PubMed ID: 19003600)
21. Genetic variation of human UDP-glucuronosyltransferase: implications in disease and drug glucuronidation.
Burchell B
Am J Pharmacogenomics; 2003; 3(1):37-52. PubMed ID: 12562215
[TBL] [Abstract][Full Text] [Related]
22. Dual polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: a novel mechanism for hyperserotoninaemia in Gilbert's syndrome mimicking carcinoid syndrome?
Lee P; Jones G; Seibel MJ
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):337-40. PubMed ID: 17353700
[TBL] [Abstract][Full Text] [Related]
23. UDP-glucuronosyltransferase activity in human liver and colon.
Strassburg CP; Nguyen N; Manns MP; Tukey RH
Gastroenterology; 1999 Jan; 116(1):149-60. PubMed ID: 9869613
[TBL] [Abstract][Full Text] [Related]
24. UDP-glucuronosyltransferases and clinical drug-drug interactions.
Kiang TK; Ensom MH; Chang TK
Pharmacol Ther; 2005 Apr; 106(1):97-132. PubMed ID: 15781124
[TBL] [Abstract][Full Text] [Related]
25. Pharmacogenomics of human uridine diphospho-glucuronosyltransferases and clinical implications.
Guillemette C; Lévesque É; Rouleau M
Clin Pharmacol Ther; 2014 Sep; 96(3):324-39. PubMed ID: 24922307
[TBL] [Abstract][Full Text] [Related]
26. Identification and validation of microRNAs directly regulating the UDP-glucuronosyltransferase 1A subfamily enzymes by a functional genomics approach.
Papageorgiou I; Court MH
Biochem Pharmacol; 2017 Aug; 137():93-106. PubMed ID: 28433553
[TBL] [Abstract][Full Text] [Related]
27. Drug metabolizing enzymes related to laboratory medicine: cytochromes P-450 and UDP-glucuronosyltransferases.
Batt AM; Magdalou J; Vincent-Viry M; Ouzzine M; Fournel-Gigleux S; Galteau MM; Siest G
Clin Chim Acta; 1994 May; 226(2):171-90. PubMed ID: 7923812
[TBL] [Abstract][Full Text] [Related]
28. The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential.
Miners JO; Mackenzie PI; Knights KM
Drug Metab Rev; 2010 Feb; 42(1):196-208. PubMed ID: 19795925
[TBL] [Abstract][Full Text] [Related]
29. Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity.
Girard H; Lévesque E; Bellemare J; Journault K; Caillier B; Guillemette C
Pharmacogenet Genomics; 2007 Dec; 17(12):1077-89. PubMed ID: 18004212
[TBL] [Abstract][Full Text] [Related]
30. Donor liver uridine diphosphate (UDP)-glucuronosyltransferase-1A1 deficiency causing Gilbert's syndrome in liver transplant recipients.
Te HS; Schiano TD; Das S; Kuan SF; DasGupta K; Conjeevaram HS; Baker AL
Transplantation; 2000 May; 69(9):1882-6. PubMed ID: 10830226
[TBL] [Abstract][Full Text] [Related]
31. Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer.
Nagar S; Remmel RP
Oncogene; 2006 Mar; 25(11):1659-72. PubMed ID: 16550166
[TBL] [Abstract][Full Text] [Related]
32. Genetic variants of UDP-glucuronosyltransferase 1A genes are associated with disease presentation and outcome in primary sclerosing cholangitis.
Weismüller TJ; Zhou T; Kalthoff S; Lenzen H; Manns MP; Strassburg CP
Liver Int; 2020 Jul; 40(7):1645-1654. PubMed ID: 32378294
[TBL] [Abstract][Full Text] [Related]
33. Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk.
Lankisch TO; Schulz C; Zwingers T; Erichsen TJ; Manns MP; Heinemann V; Strassburg CP
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):695-701. PubMed ID: 18349289
[TBL] [Abstract][Full Text] [Related]
34. The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism.
Fisher MB; Paine MF; Strelevitz TJ; Wrighton SA
Drug Metab Rev; 2001; 33(3-4):273-97. PubMed ID: 11768770
[TBL] [Abstract][Full Text] [Related]
35. Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation.
Senafi SB; Clarke DJ; Burchell B
Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):233-40. PubMed ID: 7945246
[TBL] [Abstract][Full Text] [Related]
36. Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4.
Ehmer U; Vogel A; Schütte JK; Krone B; Manns MP; Strassburg CP
Hepatology; 2004 Apr; 39(4):970-7. PubMed ID: 15057901
[TBL] [Abstract][Full Text] [Related]
37. Persistent unconjugated hyperbilirubinemia after liver transplantation due to an abnormal bilirubin UDP-glucuronosyltransferase gene promoter sequence in the donor.
Jansen PL; Bosma PJ; Bakker C; Lems SP; Slooff MJ; Haagsma EB
J Hepatol; 1997 Jul; 27(1):1-5. PubMed ID: 9252066
[TBL] [Abstract][Full Text] [Related]
38. Drug glucuronidation by human renal UDP-glucuronosyltransferases.
McGurk KA; Brierley CH; Burchell B
Biochem Pharmacol; 1998 Apr; 55(7):1005-12. PubMed ID: 9605424
[TBL] [Abstract][Full Text] [Related]
39. Gender matters: estrogen receptor alpha (ERα) and histone deacetylase (HDAC) 1 and 2 control the gender-specific transcriptional regulation of human uridine diphosphate glucuronosyltransferases genes (UGT1A).
Kalthoff S; Winkler A; Freiberg N; Manns MP; Strassburg CP
J Hepatol; 2013 Oct; 59(4):797-804. PubMed ID: 23714156
[TBL] [Abstract][Full Text] [Related]
40. [From gene to disease; unconjugated hyperbilirubinemia: Gilbert's syndrome and Crigler-Najjar types I and II].
Drenth JP; Peters WH; Jansen JB
Ned Tijdschr Geneeskd; 2002 Aug; 146(32):1488-90. PubMed ID: 12198827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
